Nitric Oxide Nasal Spray (NONS) To Treat and Prevent the Exacerbation of Infection in Individuals With Mild COVID-19
Status:
Completed
Trial end date:
2022-02-02
Target enrollment:
Participant gender:
Summary
Primary:
The primary objective of this study is to evaluate the efficacy of Nitric Oxide Nasal Spray
combined with standard supportive care compared with standard supportive care alone in adult
subjects with COVID-19 not requiring hospitalization
Secondary:
The secondary objective is to evaluate the safety and tolerability of Nitric Oxide Nasal
Spray combined with standard supportive care compared with standard supportive care alone in
adult subjects with COVID-19 not requiring hospitalization.